ANNOUNCEMENT {#s1}
============

Leishmaniasis is a vector-borne disease caused by more than 20 species of parasites in the *Viannia* and *Leishmania* subgenera, affecting millions of people yearly ([@B1], [@B2]). Cutaneous leishmaniasis (CL) is the most prevalent clinical manifestation, which usually heals spontaneously within 6 months to 3 years. Diffuse CL (DCL) is a rare and poorly understood form of CL, characterized by non-self-healing chronic lesions in large areas of the skin, with high parasite proliferation and resistance to most therapeutic agents ([@B3][@B4][@B5]). DCL is caused mostly by strains of Leishmania (*Leishmania*) *amazonensis* and Leishmania (*Leishmania*) *mexicana* in Latin America and Leishmania (*Leishmania*) *aethiopica* in the Horn of Africa. Treatment of the primary CL is required to prevent the morbidity and mortality of leishmaniasis, but the choice and effectiveness of the therapy depend on the parasite species and the host immune response ([@B1], [@B5][@B6][@B7]). Therefore, species-specific diagnostic methods are crucial for clinical management.

To increase the quality of Leishmania species reference sequences, we submitted to the database the draft genome sequences of the species L. (*L.*) *amazonensis*, L. (*L.*) *mexicana*, and L. (*L.*) *aethiopica*. The parasites listed in [Table 1](#tab1){ref-type="table"} were identified as infecting species of three CL clinical cases from French Guyana, Texas, and Ethiopia, respectively, using the CDC's current diagnostic approach ([@B8], [@B9]). A portion of each CL specimen was cultivated at 26°C in 20 ml RPMI medium (Invitrogen, GA) enriched with 0.5% HEPES, 0.25% [l]{.smallcaps}-glutamine, 0.02% folic acid, 15% fetal bovine serum, 0.02% hemin, 1% minimal essential medium (MEM) vitamin solution (100×), penicillin-streptomycin (75 I/ml to 75 μg/ml), and gentamicin (50 μg/ml) (pH 7.4). When the parasites reached log phase, 1.5-ml aliquots of the culture were preserved with 10% dimethyl sulfoxide (DMSO) in liquid nitrogen. For this study, parasites were reactivated by mixing the thawed culture aliquots with 20 ml of fresh RPMI medium. After 2 to 3 weeks of incubation, 1.0 ml of culture aliquots was centrifuged at 6,000 × g for 15 min, and the pellet was used for DNA extraction using the MagAttract high-molecular-weight (HMW) DNA kit (Qiagen, MD).

###### 

Assembly metrics for *L*. (*L.*) *amazonensis*, *L*. (*L*.) *mexicana*, and *L*. (*L*.) *aethiopica* and their corresponding reference strains

  Strain                                                                   Read type(s)       Total length (bp)   No. of scaffolds   No. of contigs   *N*~50~ length (bp)   *L*~50~   Longest contig (bp)   No. of Illumina reads   No. of PacBio reads[^*a*^](#ngtab1.1){ref-type="table-fn"}   G+C content (%)   Coverage (×)
  ------------------------------------------------------------------------ ------------------ ------------------- ------------------ ---------------- --------------------- --------- --------------------- ----------------------- ------------------------------------------------------------ ----------------- --------------
  *L*. (*L*.) a*mazonensis* CDC210-L1346                                   PacBio, Illumina   33,504,997          92                 92               850,106               12        3,425,950             30,427,462              262,667                                                      59.71             75
  *L*. (*L*.) *amazonensis* M2269[^*b*^](#ngtab1.2){ref-type="table-fn"}   454, Illumina      29,029,348          2,627              2,944            19,306                430       113,027               NA                      NA                                                           59.26             NA
  *L*. (*L*.) *mexicana* CDC215-L49                                        PacBio, Illumina   32,057,209          55                 55               825,953               11        3,409,057             30,816,844              323,584                                                      59.79             87
  *L*. (*L*.) *mexicana* U1103[^*b*^](#ngtab1.2){ref-type="table-fn"}      Sanger, Illumina   32,108,741          588                927              164,930               56        1,024,353             NA                      NA                                                           59.8              NA
  *L.* (*L*.) *aethiopica* CDC209-L1204                                    PacBio, Illumina   33,648,436          118                118              763,733               15        1,670,940             10,767,274              245,491                                                      60.38             74
  *L.* (*L*.) *aethiopica* L147[^*b*^](#ngtab1.2){ref-type="table-fn"}     Illumina           31,630,816          160                1,698            39,581                240       168,996               NA                      NA                                                           60.07             NA

NA, not available.

Indicates currently available assemblies in the public databases.

The DNA extracts were used for the preparation of Illumina MiSeq and PacBio libraries. Dual-indexed libraries using NEBNext Ultra library prep (New England BioLabs, MA) and barcoding indices were manufactured at the CDC-Biotechnology Core Facility. These libraries were sequenced on a MiSeq platform (Illumina, CA) using the MiSeq 2 × 250-cycle sequencing kit. Sequence reads were filtered, base called, and demultiplexed using bcl2fastq (v2.19), with default parameters. PacBio libraries were prepared using the standard PacBio 20-kb procedure (Pacific Biosciences, CA). The libraries were size selected using BluePippin (Sage Science, MA), bound to the polymerase using the DNA/polymerase binding kit P6 v2, loaded onto 3 to 5 single-molecule real-time (SMRT) cells, and sequenced with C4 v2 chemistry for 360-min movies on the RS II instrument (Pacific Biosciences).

The filtered PacBio (minlength = 1,000) reads were *de novo* assembled using Canu v1.6 (genomeSize = 32m) ([@B10]). After removing contigs with a coverage of \<10×, the remaining contigs were corrected with Illumina reads using unicycler_polish (default parameters; Unicycler package v4.4) ([@B11]). As shown in [Table 1](#tab1){ref-type="table"} , the resultant assemblies are more contiguous than are those in the data available in GenBank for *L.* (*L*.) *amazonensis* LeiAma1.0 ([GCA_000438535](https://www.ncbi.nlm.nih.gov/assembly/GCA_000438535)) ([@B12]), *L*. (*L*.) *mexicana* ASM23466v4 ([GCA_000234665](https://www.ncbi.nlm.nih.gov/assembly/GCF_000234665)) ([@B13]), and *L*. (*L*.) *aethiopica* L147 ([GCA_000444285](https://www.ncbi.nlm.nih.gov/assembly/GCA_000444285.2)).

 {#s2}

Data availability. {#s2.1}
------------------

The genome contigs have been deposited in GenBank under accession numbers [RZOD00000000](https://www.ncbi.nlm.nih.gov/nuccore/RZOD00000000) \[*L*. (*L*.) *amazonensis* CDC210-L1346\], [RZOC00000000](https://www.ncbi.nlm.nih.gov/nuccore/RZOC00000000) \[*L*. (*L.*) *mexicana* CDC215-L49\], and [RZOE00000000](https://www.ncbi.nlm.nih.gov/nuccore/RZOE00000000) \[*L*. (*L.*) *aethiopica* CDC209-L1204\] under BioProject number [PRJNA484340](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA484340). The accession numbers for the raw reads are [SRR8377732](https://www.ncbi.nlm.nih.gov/sra/SRR8377732), [SRR7867275](https://www.ncbi.nlm.nih.gov/sra/SRR7867275), [SRR7867276](https://www.ncbi.nlm.nih.gov/sra/SRR7867276), [SRR7867277](https://www.ncbi.nlm.nih.gov/sra/SRR7867277), [SRR8377734](https://www.ncbi.nlm.nih.gov/sra/SRR8377734), [SRR7867272](https://www.ncbi.nlm.nih.gov/sra/SRR7867272), [SRR7867273](https://www.ncbi.nlm.nih.gov/sra/SRR7867273), [SRR7867285](https://www.ncbi.nlm.nih.gov/sra/SRR7867285), [SRR7867284](https://www.ncbi.nlm.nih.gov/sra/SRR7867284), [SRR8377733](https://www.ncbi.nlm.nih.gov/sra/SRR8377733), [SRR7867278](https://www.ncbi.nlm.nih.gov/sra/SRR7867278), [SRR7867279](https://www.ncbi.nlm.nih.gov/sra/SRR7867279), [SRR7867280](https://www.ncbi.nlm.nih.gov/sra/SRR7867280), [SRR7867281](https://www.ncbi.nlm.nih.gov/sra/SRR7867281), and [SRR7867274](https://www.ncbi.nlm.nih.gov/sra/SRR7867274).
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